IP Library Assignment 056769/0136
Patent Assignment
Reel/Frame 056769/0136

Assignment of Assignor's Interest

Recorded: 2021-07-07 Pages: 16
Assignor
LEO PHARMA A/S
Executed: 2021-03-08
Assignee
UNION THERAPEUTICS A/S
TUBORG HAVNEVEJ 18, HELLERUP, 2900, DENMARK
Covered Properties (16)
Substituted Pyrazoloazepin-4-Ones and Their Use as Phosphodiesterase Inhibitors
Application: 16/468,444 →
Publication: US US20200323869A1
Substituted Pyrazoloazepin-4-Ones and Their Use as Phosphodiesterase Inhibitors
Application: 17/303,955 →
Publication: US US20220362259A1
Methods for the Preparation of 1,3-Benzodioxole Heterocyclic Compounds
Application: 16/624,491 →
Publication: US US20210147440A1
Substituted Dihydrothienopyrimidines and Their Use as Phosphodiesterase Inhibitors
Application: 16/648,263 →
Publication: US 2020/0239493
Substituted Azetidine Dihydrothienopyrimidines and Their Use as Phosphodiesterase Inhibitors
Application: 16/772,428 →
Publication: US US20210070769A1
Substituted Tetrahydropyran Dihydrothienopyrimidines and Their Use as Phosphodiesterase Inhibitors
Application: 16/772,536 →
Publication: US US20200385400A1
Substituted Azetidine Dihydrothienopyridines and Their Use as Phosphodiesterase Inhibitors
Application: 16/772,615 →
Publication: US US20210079012A1
Phosphodiesterase Inhibitors
Patent: 8,338,431 →
Application: 12/528,649 →
Publication: US US20100099688A1
Triazolopyridines as Phosphodiesterase Inhibitors for Treatment of Dermal Diseases
Patent: 8,952,162 →
Application: 13/140,505 →
Publication: US US20120028974A1
Benzodioxole or Benzodioxepine Heterocyclic Compounds as Phosphodiesterase Inhibitors
Patent: 8,980,905 →
Application: 13/806,659 →
Publication: US US20130123291A1
Benzodioxole or Benzodioxepine Heterocyclic Compounds as Phosphodiesterase Inhibitors
Patent: 9,273,064 →
Application: 14/586,681 →
Publication: US US20150111915A1
Benzodioxole or Benzodioxepine Heterocyclic Compounds as Phosphodiesterase Inhibitors
Patent: 9,637,499 →
Application: 14/872,487 →
Publication: US US20160022657A1
[1,2,4]Triazolopyridines and Their Use as Phosphodiesterase Inhibitors
Patent: 8,940,761 →
Application: 14/361,356 →
Publication: US US20140329853A1
[1,2,4]Triazolopyridines and Their Use as Phosphodiesterase Inhibitors
Patent: 9,181,248 →
Application: 14/572,218 →
Publication: US US20150105420A1
Substituted Pyrazoloazepin-4-Ones and Their Use as Phosphodiesterase Inhibitors
Application: 16/468,420 →
Publication: US US20200010477A1
Substituted Pyrazoloazepin-8-Ones and Their Use as Phosphodiesterase Inhibitors
Application: 16/468,429 →
Publication: US US20190330223A1
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 16, 2011
From: NIELSEN, SIMON FELDBAEK; VIFIAN, THOMAS; HORNEMAN, ANNE MARIE; LAU, JESPER FAERGEMANN
To: LEO PHARMA A/S
Reel/Frame 026918/0873 →
Assignment of Assignor's Interest Dec 4, 2012
From: FELDING, JACOB; LARSEN, JENS C. HOJLAND; BABU, BOLLU RAVINDRA; NIELSEN, SIMON FELDBAEK
To: LEO PHARMA A/S
Reel/Frame 029402/0398 →
Assignment of Assignor's Interest Jan 24, 2013
From: NIELSEN, SIMON FELDBAEK
To: LEO PHARMA A/S
Reel/Frame 029685/0610 →
Assignment of Assignor's Interest Jun 30, 2014
From: NIELSEN, SIMON FELDBÆK; LARSEN, JENS CHRISTIAN HØJLAND
To: LEO PHARMA A/S
Reel/Frame 033215/0081 →
Assignment of Assignor's Interest Jan 28, 2020
From: LIANG, XIFU; LARSEN, JENS; NIELSEN, SIMON FELDBAEK; ANDERSEN, PETER
To: LEO PHARMA A/S
Reel/Frame 051640/0781 →
Assignment of Assignor's Interest Mar 12, 2020
From: LIANG, XIFU; LARSEN, JENS
To: LEO PHARMA A/S
Reel/Frame 052093/0565 →
Assignment of Assignor's Interest Jul 2, 2020
From: LIANG, XIFU; LARSEN, JENS; NIELSEN, SIMON FELDBAEK; ANDERSEN, PETER
To: LEO PHARMA A/S
Reel/Frame 053109/0207 →
Assignment of Assignor's Interest Jul 2, 2020
From: DAHL, ALLAN CARSTEN; BAJTNER, JOHAN ERIKSSON; OLSEN, ESBEN PAUL KROGH; METZLER, BJORN
To: LEO PHARMA A/S
Reel/Frame 053109/0425 →
Assignment of Assignor's Interest Jul 2, 2020
From: LARSEN, JENS
To: LEO PHARMA A/S
Reel/Frame 053109/0546 →
Assignment of Assignor's Interest Aug 20, 2020
From: LARSEN, JENS; NIELSEN, SIMON FELDBAEK; ANDERSEN, PETER
To: LEO PHARMA A/S
Reel/Frame 053549/0957 →
Assignment of Assignor's Interest Sep 15, 2020
From: ANDREWS, MARK; GREVE, DANIEL RODRIGUEZ; LARSEN, JENS
To: LEO PHARMA A/S
Reel/Frame 053770/0601 →
Assignment of Assignor's Interest Sep 15, 2020
From: ANDREWS, MARK; GREVE, DANIEL RODRIGUEZ; NORREMARK, BJARNE
To: LEO PHARMA A/S
Reel/Frame 053770/0841 →
Assignment of Assignor's Interest Jul 2, 2021
From: NIELSEN, SIMON FELDBAEK
To: LEO PHARMA A/S
Reel/Frame 056741/0615 →
Assignment of Assignor's Interest Jul 2, 2021
From: NIELSEN, SIMON FELDBAEK; LARSEN, JENS CHRISTIAN HOJLAND
To: LEO PHARMA A/S
Reel/Frame 056741/0839 →
Assignment of Assignor's Interest Jul 2, 2021
From: LIANG, XIFU; LARSEN, JENS; NIELSEN, SIMON FELDBAEK; ANDERSEN, PETER
To: LEO PHARMA A/S
Reel/Frame 056742/0100 →
Assignment of Assignor's Interest Aug 2, 2022
From: LEO PHARMA A/S
To: UNION THERAPEUTICS A/S
Reel/Frame 060701/0690 →